UnitedHealth Group Director Receives Routine Dividend Grant
UNITEDHEALTH GROUP INC
Subscribe to track UNH
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
UnitedHealth Group Director Receives Routine Dividend Grant
Company: UNITEDHEALTH GROUP INC (UNH) Form: 4 | Filed: 2025/12/18 Significance: Low
Insider: MONTGOMERY RICE VALERIE MD Title: Director
Transaction: • Type: Award • Shares: 43 • Price: $0.00 • Value: $0 • Owned After: 6,940
Key Insight: A director received a minor, automatic grant of 43 shares as dividend equivalents on existing deferred stock units. This is a routine, non-discretionary transaction with no market significance.
Market Context: The transaction is negligible for a mega-cap company like UnitedHealth ($291.55B market cap), representing less than 0.00001% of shares outstanding.
Comprehensive Analysis
SEC Filing Analysis: UNITEDHEALTH GROUP INC (UNH)
Executive Summary
- Trading Significance: Low
- Key Takeaway: A director received a minor, automatic grant of 43 shares as dividend equivalents on existing stock units. This is a routine, non-discretionary transaction.
- Market Impact: Neutral. The transaction is too small to have any market impact.
Company Information
| Field | Value |
|---|---|
| Company | UNITEDHEALTH GROUP INC |
| Ticker Symbol | UNH |
| CIK | 0000731766 |
| Market Cap | $291.55 billion |
Insider Information
| Field | Value |
|---|---|
| Name | MONTGOMERY RICE VALERIE MD |
| CIK | 0001714561 |
| Title/Position | Director |
| Relationship | Director |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-12-16 |
| Transaction Code | A (Award) |
| Security Type | Common Stock |
| Shares Involved | 43 |
| Price Per Share | $0.00 |
| Total Value | $0 |
| Shares Owned After | 6,940 |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $0 |
| % of Market Cap | 0.0% |
| Shares Transacted | 43 |
| % of Shares Outstanding | <0.0001% |
| Post-Transaction Ownership | 6,940 shares (<0.001% of outstanding) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: The transaction value is $0, making it immaterial against UnitedHealth's $291.55 billion market capitalization.
- Ownership Concentration: The director's total holding of 6,940 shares is a negligible fraction of the 905.7 million shares outstanding.
- Dilution Impact: The issuance of 43 shares has no dilutive effect on existing shareholders.
- Transaction Significance: This transaction is non-discretionary, as it represents dividend equivalents paid on previously vested stock units. It does not signal any new insider sentiment.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: This is a routine, automated transaction with zero monetary value and an insignificant number of shares. It provides no new information to the market.
Volume & Sentiment
- Expected Volume Impact: None. The transaction is too small to influence trading volume.
- Sentiment Indicator: Neutral. The filing is procedural and does not reflect a bullish or bearish stance from the insider.
Additional Context
Transaction Notes
- As per the filing's footnote, the shares represent "dividend equivalents paid on vested deferred stock units." This confirms the automatic and non-discretionary nature of the acquisition.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
